Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy
Authors:
Open Access
- 15 August 2021
- journal article
- review article
- Published by SAGE Publications in Ear, Nose & Throat Journal
- Vol. 103 (2) , 100-101
Abstract
Recurrent respiratory papillomatosis is a condition caused by human papilloma virus, usually sub types 6 and 11. Papillomas are benign neoplasms that are most commonly found on the larynx and can be often associated with significant airway involvement. Frequency of episodes varies among patients as do the clinical symptoms. Patients often present with symptoms such as hoarseness but there is potential for respiratory compromise and even complete airway obstruction.Keywords
This publication has 5 references indexed in Scilit:
- Systemic bevacizumab for recurrent respiratory papillomatosis: A national surveyThe Laryngoscope, 2017
- Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a childThe Laryngoscope, 2016
- Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosisOncology Letters, 2014
- Recurrent respiratory papillomatosisArchives of Disease in Childhood, 2006
- Clinical Course of Recurrent Respiratory Papillomatosis in Danish ChildrenJAMA Otolaryngology–Head & Neck Surgery, 2004